5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.35%
Revenue growth similar to METSB.HE's 6.35%. Walter Schloss would see if both companies share industry tailwinds.
16.80%
Gross profit growth similar to METSB.HE's 16.80%. Walter Schloss would assume both firms track common industry trends.
19.63%
EBIT growth similar to METSB.HE's 19.63%. Walter Schloss might infer both firms share similar operational efficiencies.
19.63%
Operating income growth similar to METSB.HE's 19.63%. Walter Schloss would assume both share comparable operational structures.
18.73%
Net income growth comparable to METSB.HE's 18.73%. Walter Schloss might see both following similar market or cost trajectories.
21.43%
EPS growth similar to METSB.HE's 21.43%. Walter Schloss would assume both have parallel share structures and profit trends.
21.43%
Similar diluted EPS growth to METSB.HE's 21.43%. Walter Schloss might see standard sector or cyclical influences on both firms.
-2.23%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.23%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
19.74%
Similar OCF growth to METSB.HE's 19.74%. Walter Schloss would assume comparable operations or industry factors.
970.59%
FCF growth similar to METSB.HE's 970.59%. Walter Schloss would attribute it to parallel capital spending and operational models.
-26.09%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
1.14%
5Y revenue/share CAGR similar to METSB.HE's 1.14%. Walter Schloss might see both companies benefiting from the same mid-term trends.
8.90%
3Y revenue/share CAGR similar to METSB.HE's 8.90%. Walter Schloss would assume both companies experience comparable short-term cycles.
591.58%
10Y OCF/share CAGR in line with METSB.HE's 591.58%. Walter Schloss would see both as similarly efficient over the decade.
299.37%
5Y OCF/share CAGR is similar to METSB.HE's 299.37%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
258.96%
3Y OCF/share CAGR similar to METSB.HE's 258.96%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
148.99%
Similar net income/share CAGR to METSB.HE's 148.99%. Walter Schloss would see parallel tailwinds or expansions for both firms.
150.10%
5Y net income/share CAGR similar to METSB.HE's 150.10%. Walter Schloss might see both on parallel mid-term trajectories.
142.86%
3Y net income/share CAGR similar to METSB.HE's 142.86%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
53.48%
5Y equity/share CAGR is in line with METSB.HE's 53.48%. Walter Schloss would see parallel mid-term profitability and retention policies.
25.43%
3Y equity/share CAGR similar to METSB.HE's 25.43%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.29%
AR growth well above METSB.HE's 14.29%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.73%
Inventory growth well above METSB.HE's 10.73%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.40%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.83%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-11.02%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-2.89%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.